drugset / Trial / NCT05849129
Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer
Phase 2
Recruiting
90 enrolled
The Canadian College of Naturopathic Medicine
Ottawa Hospital Research Institute · collab
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
This is a two arm RCT evaluating the effect of intravenous vitamin C versus placebo in patients with incurable non-small cell lung cancer. Participants in both arms will be receiving platinum doublet chemotherapy with or without concurrent immunotherapy as standard care. We plan to enroll 90 patients over 5 years.
Timeline
- Start
- 2024-10-01
- Primary completion
- 2030-10-01
- Completion
- 2031-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin C | Other / unclassified | 1 g/kg | Intravenous |